Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now early-phase tilt small index

Stroke Sequelae: early-phase trial registry

6 of 9 indexed Stroke Sequelae trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 6 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Stroke Sequelae: 9 US clinical trials tracked, 6 recruiting.

Stroke Sequelae is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Medical University of South Carolina, running 4 of these trials.

Enrollment posture brief

Registry condition stroke-sequelae

OPEN 6 | RECR 67% | LATE 0 | EARLY 3 | RANK #1916 | SPON 4

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Stroke Sequelae (this)67%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Stroke Sequelae

Stroke Sequelae lists 6 open slots (67% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Stroke Sequelae on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Stroke Sequelae is recruiting above its size-band peers.

    6 of 9 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Stroke Sequelae research.

    Medical University of South Carolina accounts for 4 of 9 trials (44.4%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Stroke Sequelae trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 9 trials that report a genuine target (sentinel values excluded). 8 of those (88.9%) plan for fewer than 100 participants.

  4. Stroke Sequelae research is mostly interventional.

    8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 21

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1

Named interventions

Most-linked intervention names on Stroke Sequelae records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

transcutaneous auricular vagus nerve stimulation (taVNS) Device
1 trials
MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System Device
1 trials
anodal transcranial direct current stimulation (a-tDCS) Device
1 trials
Home telerehabilitation therapy Other
1 trials
Brainsight Neuronavigation System Other
1 trials
MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Sham) Device
1 trials
MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active) Device
1 trials
sham stimulation Device
1 trials

US sites by state

Facility locations filed on Stroke Sequelae trials. A trial with sites in several states counts in each.

South Carolina 4 trials
Maryland 2 trials
Massachusetts 2 trials
Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Stroke Sequelae page

9 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stroke Sequelae condition card totals 9 registered trials; most-linked intervention transcutaneous auricular vagus nerve stimulation (taVNS); top US site state South Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.